Insight

Importance of early genetic testing for prostate cancer patients

Photo of Maha Hussain from pcf.org

Aug 10, 2024, 14:33

Importance of early genetic testing for prostate cancer patients

Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust, shared on X about a recent paper by Maha Hussain et al. titled “Abiraterone, Olaparib, or Abiraterone + Olaparib in First-line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)” published in Clinical Cancer Research.

Authors: Maha Hussain et al.

Kenrick Ng

“The most impactful piece in PCa from GU24 now published in full. Strong evidence that olap+abi combination is > than sequential treatment. Highlights importance of early genetic testing for prostate cancer patients.”

Source: Kenrick Ng/X

abiraterone Arul Chinnaiyan Barts Health NHS Trust cancer Channing Paller Clinical Cancer Research Daniel Shevrin Emmanuel Antonarakis GU24 Jingsong Zhang Joel Picus Kenrick Ng Latifa Bazzi Maha Hussain Masha Kocherginsky Matthew Rettig Nabil Adra Neeraj Agarwal olaparib olaparib + abiraterone OncoDaily Oncology Robert Dreicer Russell Szmulewitz Ryan Stephenson Scott Tagawa Stephanie Daignault-Newton Timothy Kuzel Travis Gerke Young Whang Zachery Reichert

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage